Hosted on MSN6mon
Moderna plans to slash R&D, focus on commercial businessannounced plans on Thursday to cut costs and refocus on core products. Company officials bragged Thursday that they've had a higher rate of success in research and development than traditional ...
For our Core Products, operating capacity is 12% higher for the 2025 season compared to the 2024 season. As of February 23 for our Core ...
7h
Zacks Investment Research on MSNCore & Main (CNM) Stock Falls Amid Market Uptick: What Investors Need to KnowIn the latest market close, Core & Main (CNM) reached $48.27, with a -0.49% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.08%. Meanwhile, the ...
Total liquidity at year-end was $91.8 million, net cash provided by operating activities was $35.2 million, free Cash Flow 1 was $23.6 million for the year, and the Debt to Trailing Twelve Months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results